Histone gene replacement reveals a post-transcriptional role for H3K36 in maintaining metazoan transcriptome fidelity
- The University of North Carolina at Chapel Hill, United States
- Harvard Medical School, United States
- National Institute of Environmental Heatlth Science, United States
Abstract
Histone H3 lysine 36 methylation (H3K36me) is thought to participate in a host of co-transcriptional regulatory events. To study the function of this residue independent from the enzymes that modify it, we used a 'histone replacement' system in Drosophila to generate a non-modifiable H3K36 lysine-to-arginine (H3K36R) mutant. We observed global dysregulation of mRNA levels in H3K36R animals that correlates with the incidence of H3K36me3. Similar to previous studies, we found that mutation of H3K36 also resulted in H4 hyperacetylation. However, neither cryptic transcription initiation, nor alternative pre-mRNA splicing, contributed to the observed changes in expression, in contrast with previously reported roles for H3K36me. Interestingly, knockdown of the RNA surveillance nuclease, Xrn1, and members of the CCR4-Not deadenylase complex, restored mRNA levels for a class of downregulated, H3K36me3-rich genes. We propose a post-transcriptional role for modification of replication-dependent H3K36 in the control of metazoan gene expression.
Data availability
-
Histone gene replacement reveals a post-transcriptional role for H3K36 in maintaining metazoan transcriptome fidelityPublicly available at the NCBI Gene Expression Omnibus (accession no: GSE96922).
-
H3K36me3 abcam L3 Nuc Input expt.2225Publicly available at the NCBI Gene Expression Omnibus (Accession no: GSM1147189).
-
H3K36me3 abcam L3 Nuc Input expt.2226Publicly available at the NCBI Gene Expression Omnibus (Accession no: GSM1147190).
-
H3K36me3 abcam L3 Nuc ChIP expt.2259Publicly available at the NCBI Gene Expression Omnibus (Accession no: GSM1147191).
-
H3K36me3 abcam L3 Nuc ChIP expt.2260Publicly available at the NCBI Gene Expression Omnibus (Accession no: GSM1147192).
-
H3K36me1 L3 Nuc Input expt.2402Publicly available at the NCBI Gene Expression Omnibus (Accession no: GSM1147193).
-
H3K36me1 L3 Nuc Input expt.2404Publicly available at the NCBI Gene Expression Omnibus (Accession no: GSM1147194).
-
H3K36me1 L3 Nuc ChIP expt.2400Publicly available at the NCBI Gene Expression Omnibus (Accession no: GSM1147195).
-
H3K36me1 L3 Nuc ChIP expt.2401Publicly available at the NCBI Gene Expression Omnibus (Accession no: GSM1147196).
-
H3 antibody3 L3 Nuc Input expt.2222Publicly available at the NCBI Gene Expression Omnibus (Accession no: GSM1147289).
-
H3 antibody3 L3 Nuc Input expt.2224Publicly available at the NCBI Gene Expression Omnibus (Accession no: GSM1147290).
-
H3 antibody3 L3 Nuc ChIP expt.2241Publicly available at the NCBI Gene Expression Omnibus (Accession no: GSM1147291).
-
H3 antibody3 L3 Nuc ChIP expt.2242Publicly available at the NCBI Gene Expression Omnibus (Accession no: GSM1147292).
-
H3K36me2 W 14-16 hr OR Emb Input expt.2307Publicly available at the NCBI Gene Expression Omnibus (Accession no: GSM1147547).
-
H3K36me2 W 14-16 hr OR Emb Input expt.2308Publicly available at the NCBI Gene Expression Omnibus (Accession no: GSM1147548).
-
H3K36me2 W 14-16 hr OR Emb ChIP expt.2396Publicly available at the NCBI Gene Expression Omnibus (Accession no: GSM1147549).
-
H3K36me2 W 14-16 hr OR Emb ChIP expt.2397Publicly available at the NCBI Gene Expression Omnibus (Accession no: GSM1147550).
-
H4K16ac(M).L3 Input expt.2402Publicly available at the NCBI Gene Expression Omnibus (Accession no: GSM1200107).
-
H4K16ac(M).L3 Input expt.2404Publicly available at the NCBI Gene Expression Omnibus (Accession no: GSM1200108).
-
H4K16ac(M).L3 ChIP expt.2514Publicly available at the NCBI Gene Expression Omnibus (Accession no: GSM1200109).
-
H4K16ac(M).L3 ChIP expt.2515Publicly available at the NCBI Gene Expression Omnibus (Accession no: GSM1200110).
Article and author information
Author details
Funding
National Institutes of Health (For use of Harvard TRiP lines,R01-GM084947)
- Michael P Meers
- A Gregory Matera
National Cancer Institute (Ruth L. Kirschstein Predoctoral Fellowship,F31-CA177088)
- Michael P Meers
Office of the Director (Epigenomics Roadmap Project,R01-DA036897)
- Brian D Strahl
- Robert J Duronio
- A Gregory Matera
National Institute of Environmental Health Sciences (Intramural Research Program,Z01-ES101987)
- Karen Adelman
The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.
Reviewing Editor
- Elisa Izaurralde, Max Planck Institute for Developmental Biology, Germany
Version history
- Received: November 12, 2016
- Accepted: March 23, 2017
- Accepted Manuscript published: March 27, 2017 (version 1)
- Accepted Manuscript updated: April 7, 2017 (version 2)
- Version of Record published: April 25, 2017 (version 3)
Copyright
This is an open-access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication.
Metrics
-
- 3,817
- Page views
-
- 833
- Downloads
-
- 30
- Citations
Article citation count generated by polling the highest count across the following sources: Crossref, PubMed Central, Scopus.
Download links
A two-part list of links to download the article, or parts of the article, in various formats.
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Histone gene replacement reveals a post-transcriptional role for H3K36 in maintaining metazoan transcriptome fidelity
eLife 6:e23249.
https://doi.org/10.7554/eLife.23249
Further reading
-
- Chromosomes and Gene Expression
- Genetics and Genomics
Heterogeneity in endothelial cell (EC) sub-phenotypes is becoming increasingly appreciated in atherosclerosis progression. Still, studies quantifying EC heterogeneity across whole transcriptomes and epigenomes in both in vitro and in vivo models are lacking. Multiomic profiling concurrently measuring transcriptomes and accessible chromatin in the same single cells was performed on six distinct primary cultures of human aortic ECs (HAECs) exposed to activating environments characteristic of the atherosclerotic microenvironment in vitro. Meta-analysis of single-cell transcriptomes across 17 human ex vivo arterial specimens was performed and two computational approaches quantitatively evaluated the similarity in molecular profiles between heterogeneous in vitro and ex vivo cell profiles. HAEC cultures were reproducibly populated by four major clusters with distinct pathway enrichment profiles and modest heterogeneous responses: EC1-angiogenic, EC2-proliferative, EC3-activated/mesenchymal-like, and EC4-mesenchymal. Quantitative comparisons between in vitro and ex vivo transcriptomes confirmed EC1 and EC2 as most canonically EC-like, and EC4 as most mesenchymal with minimal effects elicited by siERG and IL1B. Lastly, accessible chromatin regions unique to EC2 and EC4 were most enriched for coronary artery disease (CAD)-associated single-nucleotide polymorphisms from Genome Wide Association Studies (GWAS), suggesting that these cell phenotypes harbor CAD-modulating mechanisms. Primary EC cultures contain markedly heterogeneous cell subtypes defined by their molecular profiles. Surprisingly, the perturbations used here only modestly shifted cells between subpopulations, suggesting relatively stable molecular phenotypes in culture. Identifying consistently heterogeneous EC subpopulations between in vitro and ex vivo models should pave the way for improving in vitro systems while enabling the mechanisms governing heterogeneous cell state decisions.
-
- Chromosomes and Gene Expression
We have developed a deep sequencing-based approach, Rec-Seq, that allows simultaneous monitoring of ribosomal 48S preinitiation complex (PIC) formation on every mRNA in the translatome in an in vitro reconstituted system. Rec-Seq isolates key early steps in translation initiation in the absence of all other cellular components and processes. Using this approach, we show that the DEAD-box ATPase Ded1 promotes 48S PIC formation on the start codons of >1000 native mRNAs, most of which have long, structured 5′-untranslated regions (5′UTRs). Remarkably, initiation measured in Rec-Seq was enhanced by Ded1 for most mRNAs previously shown to be highly Ded1-dependent by ribosome profiling of ded1 mutants in vivo, demonstrating that the core translation functions of the factor are recapitulated in the purified system. Our data do not support a model in which Ded1acts by reducing initiation at alternative start codons in 5′UTRs and instead indicate it functions by directly promoting mRNA recruitment to the 43S PIC and scanning to locate the main start codon. We also provide evidence that eIF4A, another essential DEAD-box initiation factor, is required for efficient PIC assembly on almost all mRNAs, regardless of their structural complexity, in contrast to the preferential stimulation by Ded1 of initiation on mRNAs with long, structured 5′UTRs.
